Page last updated: 2024-11-04

sevoflurane and Alveolitis, Fibrosing

sevoflurane has been researched along with Alveolitis, Fibrosing in 2 studies

Sevoflurane: A non-explosive inhalation anesthetic used in the induction and maintenance of general anesthesia. It does not cause respiratory irritation and may also prevent PLATELET AGGREGATION.
sevoflurane : An ether compound having fluoromethyl and 1,1,1,3,3,3-hexafluoroisopropyl as the two alkyl groups.

Research Excerpts

ExcerptRelevanceReference
"Sevoflurane is identified as an effective candidate drug for acute lung injury (ALI) treatment, but its curing effects and detailed mechanisms have not been fully disclosed."8.12Sevoflurane reduces lipopolysaccharide-induced apoptosis and pulmonary fibrosis in the RAW264.7 cells and mice models to ameliorate acute lung injury by eliminating oxidative damages. ( Fu, Z; Wu, X; Zhang, J; Zhang, Y; Zheng, F, 2022)
"The aim of this study was to explore the influences of sevoflurane inhalation therapy on circulation function and pulmonary fibrosis in rats with pulmonary arterial hypertension (PAH) and the nuclear factor-κB (NF-κB) signaling pathway."7.91Sevoflurane improves circulatory function and pulmonary fibrosis in rats with pulmonary arterial hypertension through inhibiting NF-κB signaling pathway. ( Bai, X; Li, JL; Li, SM; Xi, J; Zhao, X, 2019)
"Sevoflurane is identified as an effective candidate drug for acute lung injury (ALI) treatment, but its curing effects and detailed mechanisms have not been fully disclosed."4.12Sevoflurane reduces lipopolysaccharide-induced apoptosis and pulmonary fibrosis in the RAW264.7 cells and mice models to ameliorate acute lung injury by eliminating oxidative damages. ( Fu, Z; Wu, X; Zhang, J; Zhang, Y; Zheng, F, 2022)
"The aim of this study was to explore the influences of sevoflurane inhalation therapy on circulation function and pulmonary fibrosis in rats with pulmonary arterial hypertension (PAH) and the nuclear factor-κB (NF-κB) signaling pathway."3.91Sevoflurane improves circulatory function and pulmonary fibrosis in rats with pulmonary arterial hypertension through inhibiting NF-κB signaling pathway. ( Bai, X; Li, JL; Li, SM; Xi, J; Zhao, X, 2019)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Zheng, F1
Wu, X1
Zhang, J1
Fu, Z1
Zhang, Y1
Zhao, X1
Bai, X1
Li, JL1
Li, SM1
Xi, J1

Other Studies

2 other studies available for sevoflurane and Alveolitis, Fibrosing

ArticleYear
Sevoflurane reduces lipopolysaccharide-induced apoptosis and pulmonary fibrosis in the RAW264.7 cells and mice models to ameliorate acute lung injury by eliminating oxidative damages.
    Redox report : communications in free radical research, 2022, Volume: 27, Issue:1

    Topics: Acute Lung Injury; Animals; Antioxidants; Apoptosis; Kelch-Like ECH-Associated Protein 1; Lipopolysa

2022
Sevoflurane improves circulatory function and pulmonary fibrosis in rats with pulmonary arterial hypertension through inhibiting NF-κB signaling pathway.
    European review for medical and pharmacological sciences, 2019, Volume: 23, Issue:23

    Topics: Administration, Inhalation; Animals; Disease Models, Animal; Down-Regulation; Humans; I-kappa B Prot

2019